Technical Analysis for CNAT - Conatus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade B 5.12 -1.16% -0.06
CNAT closed down 1.16 percent on Friday, February 16, 2018, on 74 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
6 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical CNAT trend table...

Date Alert Name Type % Chg
Feb 16 200 DMA Resistance Bearish 0.00%
Feb 16 Shooting Star Candlestick Bearish 0.00%
Feb 16 Wide Bands Range Expansion 0.00%
Feb 15 Narrow Range Bar Range Contraction -1.16%
Feb 15 NR7 Range Contraction -1.16%
Feb 15 NR7-2 Range Contraction -1.16%
Feb 15 Wide Bands Range Expansion -1.16%
Feb 14 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.99%
Feb 14 Narrow Range Bar Range Contraction 0.99%
Feb 14 NR7 Range Contraction 0.99%

Older signals for CNAT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic liver failure and chronic liver failure, as well as for the patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection. The company was founded in 2005 and is headquartered in San Diego, California.
Is CNAT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.4
52 Week Low 3.88
Average Volume 422,587
200-Day Moving Average 5.2
50-Day Moving Average 4.8384
20-Day Moving Average 5.206
10-Day Moving Average 5.033
Average True Range 0.3437
ADX 24.56
+DI 24.74
-DI 17.46
Chandelier Exit (Long, 3 ATRs ) 4.9189
Chandelier Exit (Short, 3 ATRs ) 5.6311
Upper Bollinger Band 5.7191
Lower Bollinger Band 4.6929
Percent B (%b) 0.42
BandWidth 19.711871
MACD Line 0.0602
MACD Signal Line 0.0884
MACD Histogram -0.0283
Fundamentals Value
Market Cap 153.62 Million
Num Shares 30 Million
EPS -0.98
Price-to-Earnings (P/E) Ratio -5.22
Price-to-Sales 7.70
Price-to-Book 4.00
PEG Ratio -0.23
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.51
Resistance 3 (R3) 5.54 5.45 5.45
Resistance 2 (R2) 5.45 5.35 5.43 5.42
Resistance 1 (R1) 5.28 5.29 5.24 5.25 5.40
Pivot Point 5.19 5.19 5.16 5.17 5.19
Support 1 (S1) 5.02 5.09 4.98 4.99 4.84
Support 2 (S2) 4.93 5.03 4.91 4.82
Support 3 (S3) 4.76 4.93 4.80
Support 4 (S4) 4.73